129 related articles for article (PubMed ID: 3352048)
1. Intracavernous injection of vasoactive drugs after radical prostatectomy.
Goldstein M
J Urol; 1988 Apr; 139(4):800. PubMed ID: 3352048
[No Abstract] [Full Text] [Related]
2. Pharmacological treatment of erectile dysfunction after radical prostatectomy.
Dennis RL; McDougal WS
J Urol; 1988 Apr; 139(4):775-6. PubMed ID: 3352040
[TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
[No Abstract] [Full Text] [Related]
5. Intracavernous injections for impotence.
Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
[No Abstract] [Full Text] [Related]
6. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
[TBL] [Abstract][Full Text] [Related]
7. [Action of vasoactive drugs in male sexual impotence].
Morales JC; Elizondo B
Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
[TBL] [Abstract][Full Text] [Related]
8. Penile self-injection for impotence in patients after radical cystectomy-ileal loop.
Al-Juburi AZ; O'Donnell PD
Urology; 1987 Jul; 30(1):29-30. PubMed ID: 3603906
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM; Stevenson RW; Szasz G
J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
[TBL] [Abstract][Full Text] [Related]
10. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Sidi AA; Cameron JS; Duffy LM; Lange PH
J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
[TBL] [Abstract][Full Text] [Related]
11. [Penile self-injection of a papaverine-phentolamine combination, as treatment of impotence, in patients treated with radical cystoprostatectomy].
Calahorra Fernández FJ; Rodríguez A; Castro M; Tamayo JC; Alvarez E; Leiva O
Actas Urol Esp; 1991; 15(1):43-5. PubMed ID: 2058441
[TBL] [Abstract][Full Text] [Related]
12. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Chao R; Clowers DE
Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
[TBL] [Abstract][Full Text] [Related]
13. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
Kiely EA; Bloom SR; Williams G
Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
Zentgraf M; Baccouche M; Jünemann KP
Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360
[TBL] [Abstract][Full Text] [Related]
15. [Intracavernous injections for the treatment of erectile dysfunction].
Siegal YI; Lindner A
Harefuah; 1991 Nov; 121(10):391-3. PubMed ID: 1752559
[No Abstract] [Full Text] [Related]
16. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury.
Sidi AA; Cameron JS; Dykstra DD; Reinberg Y; Lange PH
J Urol; 1987 Sep; 138(3):539-42. PubMed ID: 2442418
[TBL] [Abstract][Full Text] [Related]
17. The use of vasoactive agents in the treatment of erectile impotence.
Fried FA
N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
[No Abstract] [Full Text] [Related]
18. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
Hadzija BW; Mattocks AM; Stahl GM
J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330
[TBL] [Abstract][Full Text] [Related]
20. Classification of sexual dysfunction for management of intracavernous medication-induced erections.
Fein RL
J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
